Recruiting Fibromyalgia Studies in Mesa
A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or Endometriosis
The purpose of this clinical trial to characterize changes in bone mineral density during continuous treatment with relugolix combination tablet for up to 48 months (4 years) and 1 year of post-treatm...
Study to Assess EN3835 in the Treatment of Plantar Fibromatosis (Also Known as Ledderhose Disease)
This study will assess the efficacy, safety, and tolerability of EN3835 compared to placebo in the treatment of PFI (also known as Ledderhose disease)....
About Fibromyalgia Clinical Trials in Mesa
Fibromyalgia is a condition characterized by widespread musculoskeletal pain, fatigue, sleep disturbance, and cognitive difficulties. It affects about 2-4% of the population, predominantly women. Treatment includes medications, exercise, stress management, and cognitive behavioral therapy.
There are currently 2 fibromyalgia clinical trials recruiting participants in Mesa, ARIZONA. These studies are seeking a combined 1,418 participants. Research is being sponsored by Sumitomo Pharma Switzerland GmbH, Endo Pharmaceuticals. Clinical trial participation is free and participants receive study-related medical care at no cost.
Fibromyalgia Clinical Trials in Mesa — FAQ
Are there fibromyalgia clinical trials in Mesa?
Yes, there are 2 fibromyalgia clinical trials currently recruiting in Mesa, ARIZONA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Mesa?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Mesa research site will contact you about next steps.
Are clinical trials in Mesa free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Mesa studies also compensate for your time and travel.
What fibromyalgia treatments are being tested?
The 2 active trials in Mesa are testing new therapies including novel drugs, biologics, and treatment approaches for fibromyalgia.
Data updated March 2, 2026 from ClinicalTrials.gov